杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/22 | 1,999 | 2,018 | 1,981 | 1,996 | +10 | +0.5% | 191,300 |
2020/07/21 | 1,993 | 2,003 | 1,976 | 1,986 | -30 | -1.5% | 250,300 |
2020/07/20 | 1,993 | 2,016 | 1,980 | 2,016 | +32 | +1.6% | 199,000 |
2020/07/17 | 2,019 | 2,024 | 1,968 | 1,984 | -54 | -2.6% | 363,400 |
2020/07/16 | 2,051 | 2,062 | 2,028 | 2,038 | -51 | -2.4% | 212,700 |
2020/07/15 | 2,101 | 2,130 | 2,082 | 2,089 | -13 | -0.6% | 192,000 |
2020/07/14 | 2,078 | 2,113 | 2,078 | 2,102 | +6 | +0.3% | 98,800 |
2020/07/13 | 2,068 | 2,102 | 2,055 | 2,096 | +40 | +1.9% | 123,500 |
2020/07/10 | 2,068 | 2,078 | 2,054 | 2,056 | +6 | +0.3% | 166,900 |
2020/07/09 | 2,061 | 2,067 | 2,032 | 2,050 | -13 | -0.6% | 136,800 |
2020/07/08 | 2,067 | 2,109 | 2,060 | 2,063 | -4 | -0.2% | 217,500 |
2020/07/07 | 2,104 | 2,104 | 2,033 | 2,067 | -29 | -1.4% | 230,400 |
2020/07/06 | 2,069 | 2,110 | 2,069 | 2,096 | +15 | +0.7% | 118,500 |
2020/07/03 | 2,105 | 2,105 | 2,054 | 2,081 | -11 | -0.5% | 136,900 |
2020/07/02 | 2,138 | 2,147 | 2,076 | 2,092 | -46 | -2.2% | 364,700 |
2020/07/01 | 2,212 | 2,232 | 2,133 | 2,138 | -69 | -3.1% | 174,200 |
2020/06/30 | 2,230 | 2,252 | 2,195 | 2,207 | -11 | -0.5% | 201,900 |
2020/06/29 | 2,171 | 2,234 | 2,171 | 2,218 | +2 | +0.1% | 204,800 |
2020/06/26 | 2,190 | 2,226 | 2,181 | 2,216 | +58 | +2.7% | 267,100 |
2020/06/25 | 2,162 | 2,166 | 2,131 | 2,158 | -42 | -1.9% | 318,000 |
2020/06/24 | 2,228 | 2,231 | 2,198 | 2,200 | -33 | -1.5% | 180,800 |
2020/06/23 | 2,235 | 2,257 | 2,211 | 2,233 | +5 | +0.2% | 250,700 |
2020/06/22 | 2,219 | 2,238 | 2,202 | 2,228 | +34 | +1.5% | 118,400 |
2020/06/19 | 2,181 | 2,202 | 2,160 | 2,194 | +15 | +0.7% | 199,600 |
2020/06/18 | 2,171 | 2,203 | 2,159 | 2,179 | +41 | +1.9% | 225,600 |
2020/06/17 | 2,144 | 2,165 | 2,130 | 2,138 | ±0 | ±0% | 133,100 |
2020/06/16 | 2,120 | 2,150 | 2,113 | 2,138 | +47 | +2.2% | 236,800 |
2020/06/15 | 2,114 | 2,151 | 2,089 | 2,091 | -45 | -2.1% | 115,300 |
2020/06/12 | 2,112 | 2,146 | 2,093 | 2,136 | -12 | -0.6% | 321,700 |
2020/06/11 | 2,148 | 2,157 | 2,116 | 2,148 | -16 | -0.7% | 275,600 |
2020/06/10 | 2,154 | 2,165 | 2,131 | 2,164 | +24 | +1.1% | 224,800 |
2020/06/09 | 2,168 | 2,168 | 2,092 | 2,140 | -31 | -1.4% | 392,900 |
2020/06/08 | 2,220 | 2,231 | 2,167 | 2,171 | -54 | -2.4% | 249,800 |
2020/06/05 | 2,237 | 2,238 | 2,208 | 2,225 | -24 | -1.1% | 183,800 |
2020/06/04 | 2,286 | 2,295 | 2,240 | 2,249 | -38 | -1.7% | 212,000 |
2020/06/03 | 2,300 | 2,301 | 2,256 | 2,287 | +6 | +0.3% | 230,800 |
2020/06/02 | 2,296 | 2,296 | 2,253 | 2,281 | -7 | -0.3% | 224,600 |
2020/06/01 | 2,330 | 2,334 | 2,286 | 2,288 | -43 | -1.8% | 202,100 |
2020/05/29 | 2,273 | 2,331 | 2,267 | 2,331 | +54 | +2.4% | 435,900 |
2020/05/28 | 2,237 | 2,280 | 2,225 | 2,277 | +44 | +2% | 361,700 |
2020/05/27 | 2,192 | 2,235 | 2,181 | 2,233 | +18 | +0.8% | 329,000 |
2020/05/26 | 2,231 | 2,237 | 2,193 | 2,215 | -9 | -0.4% | 206,100 |
2020/05/25 | 2,194 | 2,230 | 2,184 | 2,224 | +51 | +2.3% | 233,300 |
2020/05/22 | 2,232 | 2,239 | 2,165 | 2,173 | -82 | -3.6% | 238,200 |
2020/05/21 | 2,212 | 2,256 | 2,181 | 2,255 | +58 | +2.6% | 390,500 |
2020/05/20 | 2,160 | 2,207 | 2,160 | 2,197 | +46 | +2.1% | 270,800 |
2020/05/19 | 2,187 | 2,197 | 2,133 | 2,151 | -37 | -1.7% | 261,600 |
2020/05/18 | 2,172 | 2,195 | 2,168 | 2,188 | +30 | +1.4% | 187,000 |
2020/05/15 | 2,177 | 2,205 | 2,138 | 2,158 | -23 | -1.1% | 266,900 |
2020/05/14 | 2,220 | 2,254 | 2,181 | 2,181 | -67 | -3% | 305,200 |
1151~
1200
件表示中 / 3674件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 136,500円 | +3.2% | +4.5% | 3.81% | 15.68倍 | 0.60倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
持田薬 | 290,300円 | +3.0% | +27.5% | 2.76% | 18.38倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 138,800円 | - | - | 0.00% | - | 64.29倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
栄研化 | 201,200円 | +0.4% | -8.4% | 2.63% | 25.83倍 | 1.46倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ジーエヌアイ | 149,000円 | +21.7% | +999.9% | 0.00% | 6.20倍 | 2.05倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム